Invention Grant
- Patent Title: Vaccine adjuvants based on TLR receptor ligands
-
Application No.: US18446041Application Date: 2023-08-08
-
Publication No.: US11964014B2Publication Date: 2024-04-23
- Inventor: Helene Bazin-Lee , David Burkhart , Jay Evans
- Applicant: THE UNIVERSITY OF MONTANA
- Applicant Address: US MT Missoula
- Assignee: THE UNIVERSITY OF MONTANA
- Current Assignee: THE UNIVERSITY OF MONTANA
- Current Assignee Address: US MT Missoula
- Agency: Michael Best & Friedrich LLP
- Main IPC: A61K39/39
- IPC: A61K39/39 ; A61K39/00 ; C07F9/6561
Abstract:
Lipidated oxoadenines of formula (I) are TLR7/8 receptor ligands useful for modulating immune responses. The compounds may have therapeutic application in the treatment of cancer, infectious diseases, allergy, or autoimmune disorders.
Public/Granted literature
- US20240024469A1 VACCINE ADJUVANTS BASED ON TLR RECEPTOR LIGANDS Public/Granted day:2024-01-25
Information query
